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A B S T R A C T
It has been hypothesized that microvascular dysfunction affects endothelial dysfunction of the large
arteries, which may explain the relationship of microvascular disease with macrovascular disease.
The aim of the present study was to investigate the relationship of retinal microvascular disorders
with endothelium-dependent FMD (flow-mediated vasodilatation) and carotid IMT (intima-media
thickness). A total of 256 participants, aged 60–85 years, 70 with normal glucose metabolism,
69 with impaired glucose metabolism and 109 with Type II diabetes, were included in this study.
All participants were ophthalmologically examined, including funduscopy and two field 45◦ fundus
photography, and were graded for retinal sclerotic vessel abnormalities and retinopathy. Retinal
arteriolar and venular diameters were measured with a computer-assisted method. Brachial artery,
endothelium-dependent FMD and carotid IMT were assessed ultrasonically as measurements
of endothelial function and early atherosclerosis respectively. After adjustment for age, sex
and glucose tolerance status, retinal vessel diameters, retinal sclerotic vessel abnormalities and
retinopathy were not significantly associated with FMD. In contrast with other retinal microvascular
abnormalities, retinal venular dilatation was associated with increased IMT [standardized β value
(95% confidence interval), 0.14 (0.005–0.25)]. This association was attenuated and lost statistical
significance after adjustment for cardiovascular risk factors, in particular after correction for fasting
insulin. In the present study, retinal microvascular disorders are not independently associated with
impaired FMD. In addition, retinal venular dilatation is associated with increased IMT, although
non-significantly after multivariable adjustment for cardiovascular risk factors. Therefore our data
provide evidence that retinal microvascular disease is of limited value in risk stratification for
future cardiovascular events.
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INTRODUCTION
There is growing evidence that microvascular disease
plays a prominent role in the pathogenesis of macro-
vascular disease and mortality [1–3]. Previous studies
have shown that coronary microvascular disease may
be involved in the occurrence of myocardial infarction
without overt coronary artery blockage [4–7], heart
failure [8] andmortality aftermyocardial infarction [9]. In
addition, microvascular dysfunction in the skin, of which
the microcirculation is thought to resemble the systemic
microcirculation, has been associated with increased
coronary heart disease risk [10]. Most of these studies,
however, were carried out in experimental settings with
small sample sizes, partly because of the invasive or
laborious methods.
The retinal circulation offers a unique opportunity to
non-invasively analyse the systemic microcirculation in
large populations [11]. A new computer-assisted method
has been developed to measure retinal vessel diameters
from digitized photographs [12]. Retinal microvascular
abnormalities, such as retinal arteriolar narrowing and
retinopathy, have been associated with hypertension [13–
17], the metabolic syndrome and Type II diabetes [18,19],
and with prevalent and incident CVD (cardiovascular
disease) and mortality [2,11,20–22], suggesting that re-
tinal microvascular disorders may be a marker of athero-
sclerosis. In contrast, other studies have not shown an
evident relationship between retinalmicrovascular abnor-
malities and markers of atherosclerosis or macrovascular
disease [23–26].
Ifmicrovascular dysfunctiondoes indeed affect the risk
of atherosclerosis, the question remains through what
mechanism this occurs. We hypothesized that micro-
vascular dysfunction may be linked to atherosclerosis by
inducing endothelial dysfunction of large vessels [27]. If
this is the case, then markers of microvascular dysfunc-
tion should be associated with markers of large artery
endothelial dysfunction and of early atherosclerosis. To
test this hypothesis, we investigated cross-sectionally in
a population-based study of individuals with normal
glucose metabolism, impaired glucose metabolism and
Type II diabetes the relationship of retinal micro-
vascular abnormalities on one hand with brachial artery
endothelium-dependent FMD (flow-mediated vaso-
dilatation) [28,29] and carotid IMT (intima-media thick-
ness) on the other.
METHODS
Study population
The Hoorn Study is a population-based cohort study
of Type II diabetes and its cardiovascular complications
among 2484 Caucasian people, aged 50–75 years, which
started in 1989. Details have been described elsewhere
[30]. At baseline, an age-, sex- and glucose-tolerance
stratified subsample of 631 participants was extensively
studied for reasons of efficiency. In 2000–2001, a follow-
up examination was carried out among surviving parti-
cipants who gave their permission to be re-contacted [31].
Of the 631 participants who had an ophthalmological
examination at baseline, almost 60% dropped out for the
follow-up examination, because of the following reasons:
119 (19%) persons had died, 49 (8%) had moved out of
the region and 207 (33%) did not participate because
of mobility or health problems, or lack of motivation.
Finally, 256 people were included in the follow-up
ophthalmological examination [17], 70 with normal glu-
cose metabolism, 69 with impaired glucose metabolism
and 109 with Type II diabetes [32]. Written informed
consent was obtained from all participants. The Ethical
ReviewCommittee of the VUUniversityMedical Center
(VUmc) in Amsterdam, The Netherlands, approved the
Hoorn Study.
Ophthalmological examination and retinal
vessel diameter measurements
After mydriasis with 0.5% tropicamide and 2.5%
phenylephrine eye drops, the retina was examined by
funduscopy and fundus photography, as described previ-
ously [17]. Briefly, fundus photography was performed
with a 45◦ CR5non-mydriatic retinal camera (Canon), in-
terfaced to a 3CCD Color Video Camera (Sony). The
quality of each photo was checked immediately on a con-
nected colour video monitor (Trinitron; Sony) and a new
photograph was taken if the quality was insufficient.
The photographs were digitized, compressed (10:1
JPEG), and stored on a magneto-optical disc using the
MV-300P Viewfile system (TEAC). Two photographs
were made of each eye, one centred on the macula and
one centred on the optic disc.
Methods used to measure and summarize retinal
vessel diameters from digitized photographs followed
a standardized protocol [12]. Briefly, one investigator,
blinded to the identity of the participant, independently
measured all arterioles and venules 0.5–1 disc diameter
from the optic disc margin using a computer-imaging
program (Retinal Analysis; Optimate). The branches of
arterioles were also measured if the trunk measurements
were 85 µm. Computer-assisted measurements of the
diameters of arterioles and venules were obtained and
combined according to the revised formulas of Parr
and Hubbard [12,33–35], which account for magnifica-
tiondifferences and the number of vessels in photographs.
Average diameters of arterioles [CRAE (central retinal
arteriolar equivalents)] and venules [CRVE (central
retinal venular equivalents)] in one eye were assessed and
combined into an AVR (arteriole-to-venule ratio). An
AVR of 1.0 indicates that the diameters of the arterioles
are approximately equal to the diameters of the venules,
whereas a smaller AVR indicates narrower arterioles or
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wider venules. For each subject, one photograph centred
on the optic disc was used, alternately selected from the
left and right eye (1:1 ratio). In the case of insufficient
quality, the photograph of the other eye was examined.
Generalized arteriolar narrowing was defined as the
lowest quintile of the CRAE, and generalized venular
dilation as the highest quintile of the CRVE [19]. The
intra-observer intersession coefficients of variation [S.D.
of themean difference/(
√
2×pooledmean)] were 5% for
CRVE, 8% for CRAE and 9% for AVR.
The fundus photographs were independently analysed
by two individuals to grade retinal SVC (sclerotic vessel
abnormalities) and retinopathy. In the case of disagree-
ment, the judgment of a third investigator was taken
tobedecisive.Retinal SVCweredefined as the presence of
venous beading, focal narrowing, arteriovenous crossing
changes, ‘copper’ or ‘silver’ wiring, dilated or tortuous
retinal veins, or central or branch venular occlusion.
Retinopathy was defined as the presence of one or more
microaneurysms, haemorrhages or hard exudates, poss-
ibly in combination with areas of neovascularization,
fibrous proliferation and/or laser coagulation scars in
at least one eye according to the Eurodiab classification
[17,36].
Endothelium-dependent and
endothelium-independent vasodilatation
Endothelium-dependent FMD is largely mediated
by endothelium-derived nitric oxide and is considered
to reflect impaired endothelial function. The ultrasound
examinationwas carriedout according to the guidelines of
the International Brachial Artery Reactivity Task Force
[37]. Themeasurement protocol has been described in de-
tail previously [38]. Briefly, the diameter of the brachial
artery and peak flow velocity were assessed by use of
ultrasonography (350 Series, 7.5 MHz probe; Pie Medi-
cal) in combination with an arterial wall movement
detection system (Wall Track System; Pie Medical). FMD
was induced by placing a cuff on the forearm during
5 min with suprasystolic pressure (brachial systolic BP+
100 mmHg; where BP is blood pressure), resulting in
an increase in blood flow, and subsequently increased
shear stress after release of the cuff. Peak flow velocity
was assessed within 15 s after release of the cuff, and the
brachial diameter wasmeasured after 45, 90, 180 and 300 s
[31].
Endothelium-independent NMD (nitroglycerine-
mediated vasodilatation) is considered to reflect smooth
muscle cell function and is a control test for FMD. NMD
was defined by measuring the diameter of the brachial
artery and peak flow velocity 5 min after sublingual
administration of nitroglycerine (400 µM; Nitrolingual
Spray; Pohl-Boskamp) [31]. FMD and NMD were
defined as the absolute change in brachial artery diameter
and are expressed in mm.
IMT
IMT was measured with carotid ultrasonography as de-
scribed previously [39]. Briefly, a single observer obtained
structural properties of the right common carotid artery
with an ultrasound scanner (350 Series; 7.5-MHz linear
probe; Pie Medical). The scanner was connected to a
personal computer equippedwithwall track software (Pie
Medical) that enables measurement of IMT (in mm) [39].
Other measurements
Fasting and 2-h post-load plasma glucose levels after a
75 g OGTT (oral glucose tolerance test) were measured
in plasma and were used for classification into glucose
tolerance categories [32]. Subjects who were already
known to have diabetes or use glucose-lowering treat-
ment were excluded from the OGTT. Brachial systolic
and diastolic pressures were assessed in the left upper arm
at 5-min intervals with an oscillometric device (BP-8800;
Collin Press-Mate). Hypertension was defined as dia-
stolic BP 90 mmHg, systolic BP 140 mmHg and/or
using anti-hypertensive medication [40]. We also de-
termined HbA1c (glycated haemoglobin), fasting insulin,
serum total cholesterol, HDL (high-density lipoprotein)-
cholesterol, LDL (low-density lipoprotein)-cholesterol,
triacylglycerols (triglycerides), serum creatinine, serum
albumin, BMI (body mass index), waist and hip circum-
ferences, smoking and prior cardiovascular disease, as
described previously [3,39,41,42]. Insulin resistance was
calculated using the HOMA (homoeostasis model as-
sessment) formula (fasting insulin× fasting glucose/22.4)
[43].
Statistical analyses
Population characteristics, expressed as means+− S.D.,
percentages or medians (interquartile range) in the case
of a skewed distribution, were calculated according to
the presence of any retinal abnormality. Differences were
tested by means of an independent Student t test, χ2
test or Mann–WhitneyU test. Linear regression analyses
were used to calculate the associations of cardiovascular
risk factors, AVR,CRAE,CRVE, retinal SVC and retino-
pathy, which were regarded as independent variables,
with FMD, NMD and IMT as the dependent vari-
ables. Associations were consequently adjusted for the
stratification variables, age, sex and glucose-tolerance
status. Additionally, regression models for FMD were
adjusted for baseline diameter and increase in peak sys-
tolic velocity, and regression models for NMD were ad-
justed for baseline diameter. Next, associations were
adjusted for potential confounders, such as cardiovascular
risk factors. To make the results of linear regression
models comparable among different independent vari-
ables, standardized β values are reported. A standardized
β value of 0.1 indicates that, if the independent variable
increases by one S.D., the dependent variable increases by
0.1 S.D. Effect modification by glucose tolerance status
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Table 1 Clinical characteristics according to the presence or absence of any retinal abnormality
Values are means+− S.D., percentages or medians (interquartile range) in the case of skewed distribution. ‘Any retinal abnormality’ is defined as the presence of
generalized retinal arteriolar narrowing, generalized retinal venular dilatation, retinal sclerotic vessel abnormalities or retinopathy. P values were calculated by an
independent Student t test, Pearson’s χ 2 test or Mann–Whitney U test. ∗Calculated according to the HOMA formula [fasting insulin (pmol/l)× fasting glucose
(mmol/l)/22.4] [43].
No retinal abnormality Any retinal abnormality P value
n (male/female) 123 (63/60) 132 (69/63)
Age (years) 71+− 7 72+− 7 0.145
Diabetes (%) 43 46 0.595
HbA1c (%) 6.2+− 0.8 6.3+− 1.0 0.125
BMI (kg/m2) 27.3+− 4.0 27.6+− 4.2 0.485
Waist-to-hip ratio 0.93+− 0.09 0.95+− 0.10 0.112
Waist circumference (cm) 95.4+− 9.9 97.3+− 12.8 0.197
Hypertension (%) 74 83 0.154
Systolic BP (mmHg) 143+− 18 151+− 23 0.005
Diastolic BP (mmHg) 82+− 10 86+− 12 0.005
Total cholesterol (mmol/l) 5.8+− 1.1 5.6+− 0.9 0.064
HDL-cholesterol (mmol/l) 1.3+− 0.4 1.4+− 0.4 0.230
LDL-cholesterol (mmol/l) 3.7+− 1.0 3.5+− 0.8 0.038
Triacylglycerols (mmol/l) 1.4 (1.1–2.0) 1.4 (1.0–1.8) 0.154
Microalbuminuria (%) 13 23 0.116
Serum creatinine (µmol/l) 95+− 15 99+− 20 0.089
Fasting insulin (pmol/l) 63.0 (46.0–91.0) 67.0 (44.3–98.8) 0.441
Insulin resistance∗ 17.0 (11.9–30.0) 20.1 (12.0–33.3) 0.292
Current smoking (%) 11 12 0.920
Prior cardiovascular disease (%) 47 66 0.007
FMD (mm) 0.19+− 0.22 0.16+− 0.17 0.219
NMD (mm) 0.47+− 0.23 0.45+− 0.23 0.490
IMT (mm) 0.89+− 0.18 0.91+− 0.17 0.447
Generalized retinal arteriolar narrowing (%) 39
Generalized retinal venular dilatation (%) 39
Retinal sclerotic vessel abnormalities (%) 28
Retinopathy (%) 24
was investigated by entering a product term of glucose
tolerance status multiplied by the predictor variable in
the regression models. P values <0.05 were considered
as statistically significant. All analyses were performed in
SPSS 12.0.1 for Windows 98.
RESULTS
Of the 256 participants, six had photographs that could
not be graded for AVR and CRAE, and two had photo-
graphs that could not be graded for CRVE. FMD
examinations were missing in 52 subjects, measurements
of NMD in 64 subjects and measurements of IMT in 19
subjects, mainly because of poor definition of the arterial
wall in the case of obesity [31]. The group with missing
data had a significantly higherHbA1c level, BMI andwaist
circumference (results not shown).
Baseline characteristics
Table 1 presents the clinical characteristics of the study
population according to the presence of any retinal abnor-
mality. Systolic and diastolic BPwere significantly higher
in individuals with any retinal abnormality compared
with those without.
Retinal vascular disorders in relation
with FMD and IMT
Table 2 shows the associations of AVR, CRAE, CRVE,
retinal SVCand retinopathywith FMDand IMTafter ad-
justment for age, sex and glucose-tolerance status, and for
FMD, baseline diameter and increase in peak systolic
velocity. Retinal vessel diameter and retinopathy were
not significantly associated with FMD (Table 2). Retinal
SCV had a weak significant association with FMD,
which was attenuated and lost statistical significance
after adjustment for NMD (standardized β value, 0.09;
P= 0.16).
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Table 2 Standardized β values for FMD and IMT associated with retinal microvascular disorders
Data are expressed as standardized β values (in mm) per change of one S.D. of the independent variable to facilitate direct comparison. Associations were adjusted
for the stratification variables, age, sex and glucose tolerance status. Associations for FMD are additionally adjusted for baseline diameter and increase in peak systolic
velocity. S.D. for FMD and IMT are 0.20 and 0.18 mm respectively.
FMD IMT
Independent variables S.D. Standardized β (mm) 95 % CI Standardized β (mm) 95 % CI
AVR 0.1 0.05 − 0.08 to 0.18 − 0.04 − 0.16 to 0.09
CRAE 18.9 µm 0.02 − 0.16 to 0.21 0.09 − 0.03 to 0.21
CRVE 27.1 µm − 0.04 − 0.16 to 0.09 0.14 0.005 to 0.25
SVC Yes compared with no 0.13 0.004 to 0.26 0.01 − 0.12 to 0.14
Retinopathy Yes compared with no 0.05 − 0.08 to 0.18 0.02 − 0.11 to 0.15
Table 3 Adjusted standardized β values for IMT associated
with CRVE
Values are expressed as standardized β values (in mm) per change of one S.D.
of the independent variable to facilitate direct comparison. Similar results were
obtained when adjusted for systolic and diastolic BP (as model 3), waist-to-hip
ratio (as model 4), lipid profile (as model 5), serum creatinine (as model 6) or
insulin resistance (as model 7).
IMT
Model Added variables Standardized β 95 % CI
1 CRVE, age, sex and 0.14 0.005 to 0.25
glucose tolerance status
2 Model 1+ HbA1c 0.12 0.002 to 0.24
3 Model 1+ hypertension 0.12 0.001 to 0.24
4 Model 1+ prior CVD 0.13 0.005 to 0.26
5 Model 1+ BMI 0.13 0.006 to 0.25
6 Model 1+ total cholesterol 0.13 0.003 to 0.25
7 Model 1+ cholesterol/HDL ratio 0.13 0.005 to 0.25
8 Model 1+ microalbuminuria 0.13 0.005 to 0.25
9 Model 1+ fasting insulin 0.08 − 0.04 to 0.21
10 Model 1+ smoking 0.12 0.004 to 0.24
11 Model 1+ hypertension, 0.03 − 0.01 to 0.24
cholesterol/HDL ratio
and smoking
In contrast with other retinal microvascular abnormal-
ities, retinal venular dilatation was positively associated
with IMT (Table 2). An increase of 27.1 µm (one S.D.) in
CRVE was associated with an increase of 25 µm in IMT
(0.14 S.D.). One-by-one adjustment for cardiovascular
risk factors did not affect the association substantially,
except for insulin, after which the association attenuated
and lost statistical significance (Table 3). After multi-
variable adjustment for age, sex, glucose tolerance status,
hypertension, cholesterol/HDL ratio and smoking, the
standardized β value was 0.03 [95% CI (confidence
interval),−0.01 to 0.24]. Associations did not statistically
significantly differ over the glucose tolerance status
categories (P> 0.05).
Additional analyses
After adjustment for age, sex, glucose tolerance status
and baseline diameter, AVR, CRAE, CRVE, retinal
SVC and retinopathy were not associated with NMD
(results not shown). Exclusion of individuals using anti-
hypertensive treatment did not materially change the
associations between retinal vascular abnormalities and
FMD, NMD and IMT (results not shown). In addition,
generalized arteriolar narrowing and venular dilatation,
defined as the lowest quintile of CRAE and the highest
quintile of CRVE respectively, were not statistically
significantly associatedwith FMD,NMDor IMT (results
not shown).
DISCUSSION
This population-based study with elderly Caucasian
subjects showed that retinal vessel diameters, retinal SVC
and retinopathy were not significantly associated with
impaired FMD. Retinal venular dilatation was positively
related to increasing IMT, but adjustment for insulin
explained a considerable part of this association. Taken
together, the results of the present study do not provide
strong support to the hypothesis that retinal microvascu-
lar abnormalities are markers of microvascular dysfunc-
tion that cause large artery endothelial dysfunction or
early atherosclerosis.
The present study is the first observational study to
investigate the relationship of retinal microvascular dis-
ease with endothelium-dependent FMD. FMD is an esti-
mate of endothelial nitric oxide synthesis, which is an
important property of endothelial function. Generalized
endothelial dysfunction is considered a key factor in
the pathogenesis of atherosclerosis [28,29]. Our results
are in contrast with previous studies that have shown
positive associations of plasma markers of endothelial
dysfunction with AVR [23] and retinopathy [44,45].
However, expression of these markers and FMD may
reflect different characteristics of endothelial func-
tion. Recently, Stehouwer et al. [27] reported a linear
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association of microalbuminuria with impaired endo-
thelium-dependent FMD and suggested that endothelial
dysfunction might explain the relationship of micro-
albuminuria with CVD. If there is an association be-
tween retinal microvascular disease and macrovascular
disease, as described previously [2,20–22,46], our present
results do not support the hypothesis that large artery
endothelial dysfunction is the causal link. There might be
several explanations for ourfinding. First, the relationship
between retinal microvascular disease and macrovascular
disease may not be mediated by large artery endothelial
dysfunction, but may have different pathways. Secondly,
the retinal microcirculation may not sufficiently re-
semble the systemic microcirculation, which may still
induce large artery endothelial dysfunction. Finally, the
relationship between the subtle changes in retinal dia-
meters and other retinal disorders with FMD and IMT
may not be detectable due to a lack of power.
In the present study, we found a relationship between
retinal venular dilatation and increased IMT, which is
a marker of early atherosclerosis. This association was
largely explained by insulin, which has been suggested
to be an atherogenic factor [47,48] and has vasodilatory
effects on vascular smooth muscle cells and/or endo-
thelium [49]. The Rotterdam study reported, besides an
association of retinal arteriolar narrowing with IMT, as-
sociations of larger venular diameters with carotid artery
plaque and ankle-arm index [50], suggesting that not only
narrowed retinal arterioles, but also larger retinal venules
were associated with an adverse cardiovascular risk pro-
file. However, there is no clear explanation for the associ-
ations of venular dilatation with atherosclerosis. Further-
more, the ARIC (Atherosclerosis Risk in Communities)
study showed a relationship between retinal arteriolar
narrowing with carotid artery plaque, but not with any
other measure of atherosclerosis [23] and, in the CHS
(Cardiovascular Health Study), retinal arteriolar nar-
rowing was not associated with any early measure of
atherosclerosis [24]. Taken together, considering the in-
consistent results of previous studies, the results of our
present study lend support to the hypothesis that retinal
microvascular disease is not associated with subclinical
atherosclerosis.
Strengths of our present study include extensive
quantitative and qualitative measurements of retinal
microvascular disorders from digital fundus photographs
obtained in mydriasis in a population-based study.
We used the revised formulas of Parr and Hubbard
to quantify vessel calibre, by which the vessels are
measured independently of image scale and the number
ofmeasured vessels [35]. In addition, FMDand IMTwere
measured by an experienced investigator [31,39]. The
present studywas performed in a population-based study
with subjects with normal glucose metabolism, impaired
glucose metabolism and Type II diabetes. However,
results were similar regardless of glucose tolerance status.
The present study also had limitations. First, the large
number of non-participants in the follow-up examination
of the Hoorn Study may have implications for the inter-
pretation of our results. The large proportion of non-
participants may have limited the power, which reduces
the precision of the estimates. In addition, as almost
20% of the participants in the baseline examination had
died at follow-up and the remaining non-participants
had a higher baseline age, fasting glucose, HbA1c level
and more hypertension, we have to consider a healthy
survivor effect and selection bias. In addition, the study
participants with missing data had a significantly higher
HbA1c level, BMI andwaist circumference. Therefore the
loss of participants might be differential, thus the poss-
ibility of a relative underestimation of the true asso-
ciations has to be taken into account. Secondly, the
sample size of the follow-up studypopulation is relatively
small, in particular compared with earlier studies that
used the computer-assisted method to measure retinal
vessel diameters [11]. Therefore the effect size may be
too small to reach statistical significance in our present
study population. Thirdly, this population consists of
subjects in an age range of 60–85 years, consequentlywith
a relatively high prevalence of cardiovascular risk factors.
Therefore generalizing the results of the present study to
different populations, in particular of other age groups,
has to be done with care. Finally, the measurement of
FMD is based on several assumptions, e.g. that nitro-
glycerine entirelymimics the endogenous release of nitric
oxide [51]. Nevertheless, there is increasing evidence that
impaired endothelial-dependent vasodilatation, including
FMD, is associated with an adverse cardiovascular
outcome [52].
In conclusion, the present study shows that retinal
microvascular disease was not independently associated
with impaired FMD or increased IMT and may therefore
be of limited value in risk stratification for future vascular
events. Future prospective studies are needed to clarify
this specific issue.
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